Moderna on X: "In a Phase 2/3 trial in over 500 adults, mRNA-1273.222, induced significantly higher neutralizing antibody titers against BA.4/BA.5 compared to a booster dose of mRNA-1273. Read more: https://t.co/CPnxL03nZW https://t.co/ODihw6qtsQ" /
Safety and immunogenicity of seven COVID-19 vaccines as a third dose ( booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV- BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial -
Washington University participates in clinical trial of Moderna omicron booster – Washington University School of Medicine in St. Louis
UK begins 'booster' shot trial of 7 different COVID-19 vaccines | Reuters
Coronavirus vaccine booster trial begins in UK – POLITICO
A Bivalent Omicron-Containing Booster Vaccine against Covid-19 | NEJM
Skin Hydrating Booster Trial - Bio Aesthetic
Funding for immunocompromised COVID-19 booster trial | UNSW Newsroom
News - Major Covid-19 booster trial looks at how best to improve immunity against coronavirus in vulnerable people - University of Nottingham
Moderna COVID-19 booster clinical trial starting at UMass Chan
UC San Diego joins national trial to explore new vaccines for COVID-19 variants | University of California
Volunteers needed for expanded COVID-19 booster trial | KPWHRI
Volunteers needed for COVID-19 booster trial | KPWHRI
Global-first COVID-19 vaccine booster trial launches in Bradford – Bradford Teaching Hospitals NHS Foundation Trust
Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial | Nature Medicine
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Infectious Diseases
Intravacc launches phase 1 trial for intranasal COVID-19 booster vaccine
Booster trial aims to improve immunity in vulnerable people – UKRI
Volunteers sought for vaccine trial of COVID-19 booster | Newsroom
Major COVID-19 booster trial looks at how best to improve immunity against coronavirus in vulnerable people | NIHR
Baylor launches clinical trial for COVID-19 vaccine booster | BCM
Studying COVID-19 booster vaccines | Fall 2021 | UC Davis Health Magazine
Merah Putih Vaccine phase 3 trial conducted alongside booster trial - ANTARA News
The COV-BOOST Trial: Safety and Immunogenicity of Boosters - REBEL EM - Emergency Medicine Blog
Cambridge begins world-first COVID-19 vaccine booster study - NIHR - Cambridge Clinical Research Facility
